CTRI/2024/04/066514招募中不适用
A Clinical Study to evaluate the efficacy of skin Renew Peptide Retinol Serum for skin Brightening
Honasa Consumer Ltd.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年5月10日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- change in dark spot reduction, an evens out tone, Skin elasticity and firmness pigmentation and hyperpigmentation
研究概览
简要总结
A single blind one arm study.
Each participant entering the trial will be assigned to a regimen of investigational product, and advised to take general precautions as needed.
Subjects will be on study for up to 28 days.
Screening & Assigning: Day 0
Follow-ups: on Day 14, and Day 28
Test Product: Skin Renew Peptide Retinol Serum
Dose: gently massage approx. 8 drops serum over the face with fingers in outward manner two times a day.
Route of Administration: Topical
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 25.00 Year(s) 至 45.00 Year(s)（—）
入选标准
- •Gender: Non-pregnant, non-lactating female aged between 25 to
- •Subjects willing to give written informed consent 3) Women of childbearing potential must have a negative urine pregnancy test prior to study entry.
- •Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
- •Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
排除标准
- •Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
- •Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
- •Have open sores or open lesions in the treatment area(s).
- •Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product.
- •Have participated in any interventional clinical trial in the previous 30 days.
- •Have a known sensitivity to any of the constituents of the test product.
- •Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
- •Have a history of alcohol or illegal drug or substance abuse, or suspected alcohol or illegal drug or substance abuse in the past 2 years.
结局指标
主要结局
change in dark spot reduction, an evens out tone, Skin elasticity and firmness pigmentation and hyperpigmentation
时间窗: Day 0, Day 14 and Day 28
次要结局
- To assess the safety and tolerability(Day 0, Day 14 and Day 28)
研究者
Dr Robin Chugh
CCFT Laboratories
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
To see the effect of Nava Kashaya in the treatment of tinea infectionCTRI/2025/02/081233Department of Kayachikitsa Dr VJD Gramin Ayurved Mahavidyalaya near Renuka Mata Mandir Patur Akola60
尚未招募
不适用
A study to compare the effect of patoladi kashay and laghumanjishthadi kashay in combination with durvadi lepa in the management of dadru kushtha.CTRI/2024/12/077996Dr Jidnya Rajendra Retharekar60
已完成
不适用
Evaluation of Hydrating Cream Effect on Subjects With Dry Skin.NCT07393191Lacer S.A.35
尚未招募
不适用
Safety and efficacy check of productsCTRI/2025/01/079448VLCC Personal care Ltd.36
尚未招募
不适用
Study to assess the products safety and effectiveness on humans.CTRI/2025/07/091532Idam Natural Welness Pvt. Ltd.33